Alpha-interferon in childhood: a review.
Pediatric current and potential indications of alpha-interferon (alpha-IFN) are reviewed. Further prospective studies are needed for myeloproliferative diseases, acute leukemias, chronic hepatitis severe hemangiomas, and chronic idiopathic thrombocytopenic purpura (ITP).
Baruchel
A
A
Unité d'Hématologie Pédiatrique, Hôpital Saint-Louis, Paris, France.
Leblanc
T
T
Schaison
G
G
D002648:Child; D002908:Chronic Disease; D006391:Hemangioma / Q000188:drug therapy; D006525:Hepatitis, Viral, Human / Q000188:drug therapy; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy; D010372:Pediatrics; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins